Previous data showed the importance of α7nAChR in NNK-induced cell proliferation for lung cancer, breast cancer, and pancreatic cancer.[28, 29] Previous reports also showed that arecoline exerted a partial agonist activity with α7-nAChR in a dose-dependent manner or with habitual use. Here, CHRNA7 is linked to lung carcinoma.